Return On Equity of Kuvatris Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Kuvatris Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2021 to 30 Sep 2024.
  • Kuvatris Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2024 was -6454%, a 301% decline year-over-year.
  • Kuvatris Therapeutics, Inc. annual Return On Equity for 2023 was -957%, a 318% decline from 2022.
  • Kuvatris Therapeutics, Inc. annual Return On Equity for 2022 was 440%, a 419% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Kuvatris Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -6454% -4844% -301% 01 Jul 2024 30 Sep 2024
Q2 2024 -3167% -1851% -141% 01 Apr 2024 30 Jun 2024
Q1 2024 -1152% -4012% -140% 01 Jan 2024 31 Mar 2024
Q4 2023 -957% -1397% -318% 01 Oct 2023 31 Dec 2023
Q3 2023 -1610% 01 Jul 2023 30 Sep 2023
Q2 2023 -1316% 01 Apr 2023 30 Jun 2023
Q1 2023 2860% 01 Jan 2023 31 Mar 2023
Q4 2022 440% 01 Oct 2022 31 Dec 2022

Kuvatris Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2023 -957% -1397% -318% 01 Jan 2023 31 Dec 2023
2022 440% +355% +419% 01 Jan 2022 31 Dec 2022
2021 85% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.